Czernin J - Search Results

1

EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT).

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: czernin j. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799

2

L-Arginine normalizes coronary vasomotion in long-term smokers.

Campisi R, Czernin J, Schöder H, Sayre JW, Schelbert HR. Campisi R, et al. Among authors: czernin j. Circulation. 1999 Feb 2;99(4):491-7. doi: 10.1161/01.cir.99.4.491. Circulation. 1999. PMID: 9927394

3

Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.

Schöder H, Campisi R, Ohtake T, Hoh CK, Moon DH, Czernin J, Schelbert HR. Schöder H, et al. Among authors: czernin j. J Am Coll Cardiol. 1999 Apr;33(5):1328-37. doi: 10.1016/s0735-1097(99)00010-8. J Am Coll Cardiol. 1999. PMID: 10193735 Free article.

4

Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease.

Schöder H, Silverman DH, Campisi R, Karpman H, Phelps ME, Schelbert HR, Czernin J. Schöder H, et al. Among authors: czernin j. J Nucl Med. 2000 Jan;41(1):11-6. J Nucl Med. 2000. PMID: 10647599 Free article.

5

Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.

Schöder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. Schöder H, et al. Among authors: czernin j. J Nucl Med. 2001 Aug;42(8):1139-43. J Nucl Med. 2001. PMID: 11483671 Free article. Clinical Trial.

6

A patient with primary cardiac lymphoma.

Schöder H, Brown K, Said J, Czernin J. Schöder H, et al. Among authors: czernin j. Mol Imaging Biol. 2002 Jul;4(4):274-5. doi: 10.1016/s1536-1632(02)00009-4. Mol Imaging Biol. 2002. PMID: 14537116 No abstract available.

7

(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib.

Benz MR, Herrmann K, Walter F, Garon EB, Reckamp KL, Figlin R, Phelps ME, Weber WA, Czernin J, Allen-Auerbach MS. Benz MR, et al. Among authors: czernin j. J Nucl Med. 2011 Nov;52(11):1684-1689. doi: 10.2967/jnumed.111.095257. J Nucl Med. 2011. PMID: 22045706 Free PMC article. Clinical Trial.

8

(18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.

Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czernin J. Herrmann K, et al. Among authors: czernin j. Q J Nucl Med Mol Imaging. 2011 Dec;55(6):620-32. Q J Nucl Med Mol Imaging. 2011. PMID: 22231582 Review.

9

Evaluation of the Genisys4, a bench-top preclinical PET scanner.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. Herrmann K, et al. Among authors: czernin j. J Nucl Med. 2013 Jul;54(7):1162-7. doi: 10.2967/jnumed.112.114926. Epub 2013 Apr 29. J Nucl Med. 2013. PMID: 23628700 Free PMC article.

10

The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012.

Czernin J, Herrmann K. Czernin J, et al. Mol Imaging Biol. 2013 Aug;15(4):372-3. doi: 10.1007/s11307-013-0642-y. Mol Imaging Biol. 2013. PMID: 23689984 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page